ChoA Pharmaceutical Co., Ltd. · KRX:034940

ChoA Pharmaceutical Co., Ltd. financial statements

ChoA Pharmaceutical Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue59.3B62.7B63.0B68.9B57.6B65.4B67.5B63.1B58.9B55.6B
Cost of revenue37.4B41.5B39.2B42.6B37.3B39.0B37.8B33.9B30.5B28.7B
Gross profit21.9B21.2B23.8B26.2B20.3B26.4B29.7B29.1B28.4B26.8B
Research and development1.16B1.56B2.18B1.30B1.42B1.54B1.57B1.66B1.72B
Selling, general and administrative8.88B28.3B27.4B24.4B24.7B25.6B27.3B25.8B25.9B24.6B
Operating income-6.60B-9.70B-8.82B-589.3M-8.94B-2.72B-366.4M1.33B317.7M-4.83M
Depreciation and amortization2.43B2.21B2.22B2.24B2.89B3.05B2.81B2.11B2.10B1.84B
EBITDA-4.17B-7.49B-6.60B1.65B-6.05B333.6M2.44B3.43B2.42B1.83B
Interest expense1.19B1.12B979.3M676.4M375.6M610.7M0000
Income before tax-6.42B-10.0B-10.9B-424.4M-7.15B-1.77B-1.16B372.1M754.1M79.2M
Income tax-161.2M-33.8M-244.6M-623.1M-34.6M
Net income-6.81B-9.60B-10.5B560.7M-8.04B-1.32B-905.3M641.1M1.62B163.2M
Earnings per share, basic-1,098.42-310.02-339.3918.10-259.64-42.57-31.9822.6557.365.76

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents2.32B1.73M2.05B27.2M19.1M4.15B10.0B10.1B10.6B2.67B
Short-term investments198.1M3.38B2.31B2.47B4.47B4.90B4.47B1.82B1.64B3.12B
Receivables17.8B15.1B20.2B22.7B20.9B21.5B28.1B28.4B29.0B22.0B
Inventory11.7B12.4B13.0B10.9B10.3B12.6B9.14B9.21B9.10B6.66B
Current assets35.1B39.7B42.2B48.2B46.5B47.3B53.8B53.4B52.7B44.7B
Property, plant and equipment19.7B20.4B25.0B24.1B22.2B21.5B20.0B19.9B21.5B
Goodwill000046.8M46.8M
Total assets64.7B71.3B74.2B85.6B80.5B82.4B86.7B84.0B83.5B75.1B
Accounts payable3.49B4.87B5.50B4.99B3.69B3.60B3.50B2.44B2.65B2.62B
Current liabilities35.8B36.7B29.2B27.3B24.3B19.2B23.4B24.3B16.5B24.1B
Long-term debt1.97B1.58B1.10B1.90B1.00B03.95B1.00B8.92B0
Total debt5.80B8.93B6.55B16.7B
Total liabilities42.9B39.9B35.5B32.8B30.6B24.1B33.7B30.1B29.3B27.3B
Shareholders' equity25.0B31.4B41.0B52.8B49.9B58.3B53.1B54.0B54.2B47.8B
Shares outstanding6.20M31.0M31.0M31.0M31.0M31.0M28.3M28.3M28.3M28.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-4.18B-4.47B-1.48B-1.44B-1.48B1.92B4.16B2.04B-675.5M930.4M
Capital spending-1.14B-780.4M-942.7M-2.92B-3.86B-3.60B-1.39B-1.97B-412.5M-2.30B
Free cash flow-5.32B-5.25B-2.42B-4.36B-5.34B-1.72B1.46B72.1M-1.09B-1.37B
Cash from investing-1.80B731.4M-1.55B-1.87B-4.04B-2.37B-1.42B824.0M-1.87B
Cash from financing6.19B-1.69B1.81B4.82B-3.83B-2.09B-1.20B7.85B-598.0M
Share buybacks0-15.7K
Change in cash227.6M50.0M-2.48B-1.22B1.58B-5.87B-100.1M-441.8M7.91B-1.51B